This Week in Hearing

Featured image for “From OTC to Prescription Hearing Aids: Eargo Broadens Its Hearing Solution Offerings”
Oct. 11, 2024

From OTC to Prescription Hearing Aids: Eargo Broadens Its Hearing Solution Offerings

HHTM
Building on their reputation as a direct-to-consumer innovator, Eargo is now entering the prescriptive hearing aid market, offering patients and audiologists a new level of control and care with their cutting-edge devices. CEO Bill Brownie reflects on Eargo’s journey, highlighting how their invisible, rechargeable devices have evolved to meet the demands of patients who want both cutting-edge technology and expert
Featured image for “The Latest Advances in Otoprotective Agents with Ting Therapeutics CEO, Dr. Jian Zuo”
Oct. 08, 2024

The Latest Advances in Otoprotective Agents with Ting Therapeutics CEO, Dr. Jian Zuo

HHTM
Jian Zuo, CEO of Ting Therapeutics, discusses the latest updates on otoprotective agents for three conditions: antibiotic-induced hearing loss, cisplatin-induced hearing loss, and noise-induced hearing loss. Dr. Zuo explains the science behind the company’s innovative drug candidates and how they aim to address the unmet need for hearing protection. He provides an overview of Ting Therapeutics’ preclinical research, outlining key
Featured image for “Communicating Clearly and Ethically about Hearing Loss, Cognitive Decline and Dementia”
Oct. 02, 2024

Communicating Clearly and Ethically about Hearing Loss, Cognitive Decline and Dementia

HHTM
How do we communicate the link between hearing loss and cognitive decline without misleading patients? In this keynote session from the 2024 Academy of Doctors of Audiology conference, Dr. Jan Blustein dives deep into the challenge of delivering clear and ethical messages about hearing health. She addresses the common pitfalls in public health communication, such as headlines that claim “hearing
Featured image for “Practical Applications of Ototoxicity Monitoring: Patient Case Studies”
Sep. 25, 2024

Practical Applications of Ototoxicity Monitoring: Patient Case Studies

HHTM
Host Bob Traynor continues his conversation with Renee Lefrancois, Director of Audiology at Shoebox, on the vital role of ototoxicity monitoring. Renee explains the different types of ototoxicity, including cochleotoxicity, vestibulotoxicity, and neurotoxicity, and how early signs like hearing loss, tinnitus, and balance issues can indicate ototoxic damage. The conversation emphasizes the global need for ototoxicity monitoring, particularly in areas
Featured image for “Improving Access to Ototoxicity Monitoring for Patients and Clinicians”
Sep. 24, 2024

Improving Access to Ototoxicity Monitoring for Patients and Clinicians

HHTM
Ototoxicity monitoring is a vital tool for preserving hearing in patients undergoing treatments with ototoxic medications, such as those used for cancer or tuberculosis. Bob Traynor and Renee Lefrancois from Shoebox Audiometry discuss the practical applications of this monitoring and how accessible tools are making it easier for clinicians to integrate into patient care. Renee explains the global implications of
Featured image for “ADA AuDacity 2024 Featured Keynote: Innovation Update in Hearing Care”
Sep. 19, 2024

ADA AuDacity 2024 Featured Keynote: Innovation Update in Hearing Care

HHTM
At the 2024 Academy of Doctors of Audiology conference, a panel featuring Andrew Bellavia, Steve Taddei, and David Kemp provided insights into current innovations in hearing healthcare with a focus on the integration of artificial intelligence (AI) in diagnostics, devices, and care delivery. The wide-ranging discussion began by diving into how AI-driven tools such as automated audiograms, real-ear measurements, and
Featured image for “Mark Schulman on Hearing Loss, Tinnitus and Rocking the Stage with Purpose”
Sep. 09, 2024

Mark Schulman on Hearing Loss, Tinnitus and Rocking the Stage with Purpose

HHTM
Join Gael Hannan as she chats with legendary drummer and keynote speaker Mark Schulman. With an impressive career spanning over 30 years, Mark has played for musical legends like Pink, Cher, Billy Idol, Foreigner and Stevie Nicks, performing for over a billion people. Mark opens up about his journey with hearing loss and tinnitus, a challenge he has faced throughout
Featured image for “Magnetic Nanoparticles: The Future of Hearing Loss Treatment? Exploring the Latest Research with Dr. Daniel Sun”
Sep. 03, 2024

Magnetic Nanoparticles: The Future of Hearing Loss Treatment? Exploring the Latest Research with Dr. Daniel Sun

HHTM
This week we are joined by Dr. Daniel Sun, Director of the Division of Neurotology and Associate Professor of Otolaryngology at the University of Cincinnati College of Medicine, to discuss his pioneering research in hearing loss treatment. Addressing the challenges of delivering large molecule medications to the inner ear, Dr. Sun introduces a novel approach using magnetic nanoparticles. These particles,
Featured image for “Inside Sony’s CRE-C20 Hearing Aids: A Detailed Overview with Dr. Annie Duchen”
Aug. 27, 2024

Inside Sony’s CRE-C20 Hearing Aids: A Detailed Overview with Dr. Annie Duchen

HHTM
Sony has introduced the CRE-C20, the latest addition to its line of over-the-counter (OTC) hearing aids. Building on the success of the CRE-C10, the new CRE-C20 retains the sleek, completely-in-canal (CIC) design while offering significant enhancements like a built-in rechargeable battery that delivers up to 28 hours of continuous use. The CRE-C20 is designed for individuals with mild to moderate
Featured image for “Exploring Phonak’s Revolutionary Infinio Hearing Aids with Those Who Made It Happen”
Aug. 20, 2024

Exploring Phonak’s Revolutionary Infinio Hearing Aids with Those Who Made It Happen

HHTM
Host Andrew Bellavia takes us on an in-depth exploration of Phonak’s latest hearing aid platform, Infinio, which features a number of benefits both for the hearing professional at the fitting and for the end-user in daily life. The most exciting innovation is in the model named Sphere which incorporates a powerful deep neural network chip to perform speech and noise